We first validated the candidate proteins CIP2A, PRNP, VCP, CRHBP, IGFBP3, and PEPD in T2DM-nMCI (n = 30) and T2DM-MCI (n = 30) patients. This evidence concerns the gene PRNP and type 2 diabetes mellitus.